Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CARBILEV

CARBIDOPA; LEVODOPA

Standard Dose
25MG;100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CARBILEV is listed in Drugs@FDA under application 076643 (ANDA).

Marketing status: Discontinued Active ingredient CARBIDOPA; LEVODOPA Form and strength TABLET, FOR SUSPENSION;ORAL - 25MG;100MG Sponsor RANBAXY Submission history Latest submission status date: 2005-06-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview CARBILEV is listed in Drugs@FDA under application 076643 (ANDA). Marketing status: Discontinued Active ingredient CARBIDOPA; LEVODOPA Form and strength TABLET, FOR SUSPENSION;ORAL - 25MG;100MG Sponsor RANBAXY Submission history Latest submission status date: 2005-06-10 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
CARBILEV (CARBIDOPA; LEVODOPA) | Drug Monograph | MedicHelpline